Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria

NCT06559618 is registered in ClinicalTrials.gov with Barbara Trautner as lead sponsor.

NCT NCT06559618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06559618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria
Lead sponsor
Barbara Trautner
Phase
Phase 1
Overall status
Recruiting
Start date
February 3, 2025
Completion date
December 31, 2028
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic bacteriuria, bacteriuria, escherichia coli, spinal cord injuries